<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37312164</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1752-1947</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of medical case reports</Title><ISOAbbreviation>J Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report.</ArticleTitle><Pagination><StartPage>242</StartPage><MedlinePgn>242</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">242</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-023-03981-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lupus nephritis and lupus erythematosus tumidus (LET) are uncommon manifestations of systemic lupus erythematosus (SLE), and their coexistence as the initial presentation of SLE is exceedingly rare. Here, we report such a case, emphasizing the diagnostic challenges and therapeutic implications of this unusual association.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="METHODS">A 38-year-old North African woman presented in Nephrology department with a history of lower extremity edema, fatigue, and weight loss of 3&#xa0;kg in 4&#xa0;weeks. Physical examination revealed LET lesions on the chest and the Neck. Laboratory investigations showed lymphopenia, low C3 and C4 complement levels, positive antinuclear antibodies, anti-dsDNA antibodies, and anti-SSA/Ro antibodies. Renal function tests showed normal serum creatinine and nephrotic proteinuria. Renal biopsy revealed Class V lupus nephritis. Skin biopsy confirmed the diagnosis of LET, with the presence of lymphohistiocytic infiltrates and dermal mucin. The patient was diagnosed with SLE based on the 2019 EULAR/ACR criteria and treated with prednisone (1&#xa0;mg/kg/day) and hydroxychloroquine. She showed significant improvement in her cutaneous and renal symptoms at 6 and 12 months follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The rarity of the coexistence of LET and lupus nephritis as the initial manifestation of SLE, especially in the North African population, underscores the need for further research to elucidate the immunopathogenic mechanisms and prognostic factors associated with this association.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hajji</LastName><ForeName>Meriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7268-2384</Identifier><AffiliationInfo><Affiliation>Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia. meriam.hajjiwm@hotmail.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Pathology Laboratory LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia. meriam.hajjiwm@hotmail.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia. meriam.hajjiwm@hotmail.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorsane</LastName><ForeName>Imen</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Pathology Laboratory LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badrouchi</LastName><ForeName>Samaraa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Pathology Laboratory LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litaiem</LastName><ForeName>Noureddine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rammeh</LastName><ForeName>Soumaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Hamida</LastName><ForeName>Fethi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Kidney Pathology Laboratory LR00SP01, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abderrahim</LastName><ForeName>Ezzeddine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Charles Nicolle Hospital, Tunis, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine of Tunis, El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Case Rep</MedlineTA><NlmUniqueID>101293382</NlmUniqueID><ISSNLinking>1752-1947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008179" MajorTopicYN="Y">Lupus Erythematosus, Discoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glomerulonephritis</Keyword><Keyword MajorTopicYN="N">Lupus erythematosus tumidus</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">Systemic lupus</Keyword><Keyword MajorTopicYN="N">Tumid lupus</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37312164</ArticleId><ArticleId IdType="pmc">PMC10265877</ArticleId><ArticleId IdType="doi">10.1186/s13256-023-03981-3</ArticleId><ArticleId IdType="pii">10.1186/s13256-023-03981-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whittall Garcia LP, Gladman DD, Urowitz M, et al. New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE. Ann Rheum Dis. 2021;80:767&#x2013;774. doi: 10.1136/annrheumdis-2020-218670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218670</ArticleId><ArticleId IdType="pubmed">33452003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann E. Demonstrationen: lupus erythematodes tumidus. Derm Zeitschr. 1909;16:159&#x2013;160.</Citation></Reference><Reference><Citation>Choonhakarn C, Poonsriaram A, Chaivoramukul J. Lupus erythematosus tumidus. Int J Dermatol. 2004;43(11):815. doi: 10.1111/j.1365-4632.2004.02073.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-4632.2004.02073.x</ArticleId><ArticleId IdType="pubmed">15533063</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsinakidis N, Kautz O, Gibbs BF, Raap U. Lupus erythematosus tumidus: clinical perspectives. Clin Cosmet Investig Dermatol. 2019;12:707&#x2013;719. doi: 10.2147/CCID.S166723.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CCID.S166723</ArticleId><ArticleId IdType="pmc">PMC6778445</ArticleId><ArticleId IdType="pubmed">31632119</ArticleId></ArticleIdList></Reference><Reference><Citation>Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico-pathologic correlation. Ital J Dermatol Venereol. 2018;153(2):216&#x2013;229. doi: 10.23736/S0392-0488.18.05929-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0392-0488.18.05929-1</ArticleId><ArticleId IdType="pubmed">29368845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol. 2003;48:901&#x2013;908. doi: 10.1067/mjd.2003.435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mjd.2003.435</ArticleId><ArticleId IdType="pubmed">12789183</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexiades-Armenakas MR, Baldassano M, Bince B, et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum. 2003;49(4):494&#x2013;500. doi: 10.1002/art.11206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11206</ArticleId><ArticleId IdType="pubmed">12910555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehman P. Lupus erythematosus tumidus: a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136:1033&#x2013;1041. doi: 10.1001/archderm.136.8.1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archderm.136.8.1033</ArticleId><ArticleId IdType="pubmed">10926740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gougerot H, Burnier R. Lupus &#xe9;ryth&#xe9;mateux tumidus. Bull Soc Fr Dermatol Syphil. 1930;37:1219&#x2013;1292.</Citation></Reference><Reference><Citation>Rockl H. Erythematodes tumidus; a case history with reference to the problem of erythematodic lymphocytoma. Hautarzt. 1954;5:422&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">13221143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;nhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011;164(6):1335&#x2013;1341. doi: 10.1111/j.1365-2133.2011.10272.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2133.2011.10272.x</ArticleId><ArticleId IdType="pubmed">21574972</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolly M, Laumann AE, Shea CR, Utset TO. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004;13(1):64&#x2013;69. doi: 10.1191/0961203304lu473cr.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203304lu473cr</ArticleId><ArticleId IdType="pubmed">14870920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang S, Li L. A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus. Medicine (Baltimore) 2018;97(16):e0375. doi: 10.1097/MD.0000000000010375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000010375</ArticleId><ArticleId IdType="pmc">PMC5916671</ArticleId><ArticleId IdType="pubmed">29668590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mond CB, Peterson MG, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum. 1989;32:202&#x2013;204. doi: 10.1002/anr.1780320213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anr.1780320213</ArticleId><ArticleId IdType="pubmed">2493253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LA, Frank MB, McCubbin VR, Reichlein M. Autoantibodies of neonatal lupus erythematosus. J Invest Dermatol. 1994;102:963&#x2013;969. doi: 10.1111/1523-1747.ep12384148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1523-1747.ep12384148</ArticleId><ArticleId IdType="pubmed">8006461</ArticleId></ArticleIdList></Reference><Reference><Citation>Sontheimer RD. Questions pertaining to the true frequencies with which anti-Ro/SSA autoantiboby and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients. J Am Acad Dermatol. 1987;16:130&#x2013;134. doi: 10.1016/S0190-9622(87)80178-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0190-9622(87)80178-0</ArticleId><ArticleId IdType="pubmed">3492520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Caruncho C, Bielsa I, Fern&#xe1;ndez-Figueras MT, Roca J, Carrascosa JM, Ferr&#xe1;ndiz C. Lupus erythematosus tumidus: a clinical and histological study of 25 cases. Lupus. 2015;24(7):751&#x2013;755. doi: 10.1177/0961203314560204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314560204</ArticleId><ArticleId IdType="pubmed">25413356</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama M, Kanazawa N, Hiroi A, Furukawa F. Lupus erythematosus tumidus in Japan: a case report and a review of the literature. Mod Rheumatol. 2009;19(5):567&#x2013;572. doi: 10.3109/s10165-009-0192-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-009-0192-y</ArticleId><ArticleId IdType="pubmed">19562251</ArticleId></ArticleIdList></Reference><Reference><Citation>Logothetis CN, Konstantinov NK, Reyes MD, Emil NS, Tzamaloukas AH. Development of lupus erythematosus tumidus during the course of systemic sclerosis. Cureus. 2021;13(9):e18064. doi: 10.7759/cureus.18064.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18064</ArticleId><ArticleId IdType="pmc">PMC8520756</ArticleId><ArticleId IdType="pubmed">34671535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Bouaziz JD, Costedoat-Chalumeau N, Franc&#xe8;s C, Arnaud L. Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis. Br J Dermatol. 2017;177(1):188&#x2013;196. doi: 10.1111/bjd.15312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.15312</ArticleId><ArticleId IdType="pubmed">28112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Franc&#xe8;s C, Barete S, Amoura Z, Arnaud L. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. J Am Acad Dermatol. 2015;72(4):634&#x2013;639. doi: 10.1016/j.jaad.2014.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2014.12.025</ArticleId><ArticleId IdType="pubmed">25648824</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsinakidis N, Wenzel J, Landmann A, et al. Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. Exp Dermatol. 2012;21(12):958&#x2013;961. doi: 10.1111/exd.12035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.12035</ArticleId><ArticleId IdType="pubmed">23171460</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>